The global Radiotherapy Market reached USD 7.1 billion in 2024 and is projected to grow to USD 9.9 billion by 2033, at a CAGR of 3.8%. Rapidly rising cancer incidence, advanced tumor targeting, and expanding healthcare spending are fueling its growth. Enhanced treatment precision from technological innovations and growing market awareness continue to drive demand for this non-invasive cancer therapy.

STUDY ASSUMPTION YEARS:

• BASE YEAR: 2024
• HISTORICAL YEAR: 2019–2024
• FORECAST YEAR: 2025–2033

Radiotherapy Market Key Takeaways

• USD 7.1 bn in 2024 - USD 9.9 bn by 2033 (CAGR 3.8%), highlighting sustained upward market momentum 
• North America leads, capturing over 35.8% of global market share in 2024.
• By Type: Major segments include External Beam Radiation Therapy, Internal/Brachytherapy, and Systemic Radiation Therapy.
• By Application: Utilized across skin, head & neck, breast, prostate, cervical, lung cancers, and more.
• By End User: Services delivered via hospitals, cancer research institutes, and ambulatory & radiotherapy centers.
• Growth drivers: Increasing cancer cases, technological progress, government policies, and rising healthcare awareness are fueling market expansion.

Market Growth Factors

1. Rising Global Cancer Cases
The increasing number of cancer diagnoses worldwide is a primary driver. As the global population ages and lifestyles change, the incidence of various cancers rises, creating a greater demand for effective and reliable treatment options like radiotherapy. This growing patient base directly fuels the need for more radiotherapy facilities and advanced equipment.

2. Technological Advancements in Treatment
Constant innovation is revolutionizing radiotherapy. The development of advanced technologies like image-guided radiation therapy (IGRT) and intensity-modulated radiation therapy (IMRT) allows for greater precision. These technologies enable doctors to target tumors more accurately, minimizing damage to surrounding healthy tissues and improving patient outcomes.

3. Growing Demand for Non-Invasive Therapy

Patients are increasingly seeking non-surgical and less invasive cancer treatments. Radiotherapy offers a compelling alternative to surgery in many cases, providing effective tumor control with fewer side effects and a quicker recovery time, which makes it a preferred option for both patients and healthcare providers.

Request for a sample copy of this report: 

https://www.imarcgroup.com/radiotherapy-market/requestsample

Market Segmentation

Breakdown by Type:

• External Beam Radiation Therapy
• Internal Radiation Therapy / Brachytherapy
• Systemic Radiation Therapy

Breakdown by Application:

• Skin and Lip Cancer
• Head and Neck Cancer
• Breast Cancer
• Prostate Cancer
• Cervical Cancer
• Lung Cancer
• Others

Breakdown by End User:

• Hospitals
• Cancer Research Institutes
• Ambulatory and Radiotherapy Centers

Breakup by Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

Regional Insights

North America leads the global radiotherapy market, holding over 35.8% share in 2024, driven by advanced healthcare infrastructure, favorable reimbursement policies, and early technology adoption. Strong awareness and high cancer prevalence have made the region a consistent growth engine for global radiotherapy.

Recent Developments & News

The latest innovations in the radiotherapy market reflect a clear trend toward precision and minimally invasive solutions. Advanced technologies like proton therapy and stereotactic radiosurgery are being increasingly adopted, minimizing damage to healthy tissue. Artificial intelligence is also enhancing treatment planning and delivery accuracy. Additionally, strategic collaborations between healthcare providers and tech firms are accelerating the development of personalized oncology solutions, further broadening access to state-of-the-art radiotherapy.

Key Players

Accuray Incorporated, Becton Dickinson and Company, Eckert & Ziegler, Elekta AB (publ), General Electric Company, Hitachi Ltd, Ion Beam Applications, Isoray Inc., Mevion Medical Systems Inc., Nordion Inc. (Sotera Health), Siemens Healthineers AG (Siemens AG), etc.

Ask Analyst for Customization: 

https://www.imarcgroup.com/request?type=report&id=4413&flag=C

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include a thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape, benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:
IMARC Group
134 N 4th St., Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: (+1-201971-6302)